1、 英国首台工业用途的人形机器人亮相 总部位于伦敦的机器人和人工智能公司 Humanoid 于 9 月 18 日发布了 HMND 01 Alpha 原型。Humanoi d 的机器人身高近87 英寸（220 厘米），时速可达 4.4 英里（7.2 公里），可承载 33 磅（15 公斤）或以 上的有效载荷。该模型是英国第一款用于工业用途的人形机器人，旨在执行物流、零售和制造领域的复杂 任务。该公司成立仅一年，已完成两项现实世界的概念验证 (POC)，并组建了一支由约 170 名世界级工程 师、机器人专家和人工智能专家组成的强大团队。HMND 01 Alpha 仅用了七个月就完成了打造。这款轮 式机器人由 NVIDIA 最新发布的 Jetson Thor 平台驱动，该平台为其配备了强大的"机器人大脑"，可帮助 其自主思考和行动。除了专为物流设计的轮式版本外，该团队称还测试了一款面向未来消费者使用的双足 HMND 01模型。这两款系统均设计用于工厂车间和商店过道等狭小空间，这些空间对精准度、灵活性和 自主决策至关重要。 2、 OpenMind 发布智能机器人开源操作系统 OpenMind 公司今天宣布发布其开源操 ...

Core Insights - Siemens Healthineers and Stryker are collaborating to develop a neurosurgical robot for vascular interventions, aiming to enhance surgical precision and reduce treatment time for conditions like stroke and aneurysms [1][2][4] Group 1: Collaboration Details - The partnership focuses on multiple development aspects, including robot system design, integration of devices and consumables, imaging navigation, and optimization of surgical workflows [2] - Siemens previously halted its cardiac intervention robot applications, indicating a renewed commitment to the vascular intervention robot sector through this collaboration [2][5] Group 2: Market Context - The neurosurgical robot market is experiencing high growth, with over 400,000 neurosurgical procedures performed annually in China, and a projected 10% year-on-year growth in the market by mid-2025 [6] - The collaboration aims to address the shortcomings of previous robotic systems, particularly in terms of consumable compatibility and procedural support [5][6] Group 3: Competitive Landscape - The global landscape includes several approved vascular intervention robots, with Siemens' CorPath GRX being a notable player, although its commercial performance has been limited [7][8] - Domestic companies are advancing rapidly, with several products already approved and demonstrating innovative features like force feedback technology [8][9] Group 4: Technological and Commercial Outlook - The vascular intervention robot sector is entering an "innovation active period," with companies accelerating product iterations and reducing costs [9] - Successful commercialization hinges on the ability to integrate robotic systems with consumable products, as demonstrated by recent successes in the Chinese market [8][9]

Core Insights - Siemens Healthineers and Stryker have announced a strategic partnership in the field of neurovascular interventional surgery robots [1] Company Collaboration - The two companies will jointly develop a new robotic system designed to perform various elective and acute neurovascular surgeries, including treatments for stroke and cerebral aneurysms [1]